A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bonan Lv
Hebei General Hospital
Principal Investigator - Dan Liu
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Principal Investigator - Gang Zhao
First Affiliated Hospital of Heilongjiang Chinese Medicine University
Principal Investigator - Haofu Wang
The Affiliated Hospital of Qingdao University
Principal Investigator - Jichun Zhao
West China Hospital
Principal Investigator - Jun Zhao
Shanghai Sixth People Hospital
Principal Investigator - Qi Wang
The First Hospital of Jilin University
Principal Investigator - Weiguang Guo
Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
Principal Investigator - Xiangchen Dai
Tianjing Medical University General Hospital
Principal Investigator - Xiwei Zhang
The First Affiliated Hospital with Nanjing Medical University
Principal Investigator - Yongquan Gu
Xuanwu Hospital, Beijing
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Xuanwu Hospital Capital Medical University
Beijing, China
Yongquan GuRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2016
- Primary completion
- 31 Jul 2017
- Completion
- 31 Dec 2017
- Last update posted
- 10 Mar 2017
- Registered enrollment
- 160
- Registry id
- NCT02877173
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.